The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Daniel J. Blackman

Showing 1-7 of 7 articles
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Coronary interventions
Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation
Dobson L, Musa T, Uddin A, Fairbairn T, Swoboda P, Ripley D, Garg P, Evans B, Malkin C, Blackman D, Plein S, Greenwood J
June 2, 2017 | 10.4244/EIJ-D-16-00558
Interventions for valvular disease
Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry
Malkin C, Long W, Baxter P, Gale C, Wendler O, Monaghan M, Thomas M, Ludman P, De Belder M, Cunningham A, Moat N, Blackman D
February 19, 2016 | 10.4244/EIJY14M12_12
Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population
Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D
May 21, 2013 | 10.4244/EIJV9I1A17
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design
Kelly D, McCann G, Blackman D, Curzen N, Dalby M, Greenwood J, Fairbrother K, Shipley L, Kelion A, Heatherington S, Khan J, Nazir S, Alahmar A, Flather M, Swanton H, Schofield P, Gunning M, Hall R, Gershlick A
February 22, 2013 | 10.4244/EIJV8I10A183
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N
September 30, 2011 | 10.4244/EIJV7I5A99

Latest news

NEW ISSUE
Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…
January 20, 2021
NEW
Elective Cardiac Invasive Procedures during the COVID-19 Outbreak
A. Chieffo et al.
January 8, 2021
Editorial
Moving (re-shaping) the mitral annulus
Georg Nickenig
January 20, 2021
Trials Book
SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS
(Thanks to the support of Biotronik)
January 13, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Use of intravascular OCT or IVUS to guide stent implantation.
Evelyn Regar
January 20, 2021
JAA
Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...
January 12, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke